Efficacy of a home discharge care bundle after acute exacerbation of COPD.
Aged
Delivery of Health Care, Integrated
Disease Progression
Female
France
Home Care Services
Humans
Length of Stay
Male
Middle Aged
Patient Care Bundles
Patient Discharge
Patient Readmission
Program Evaluation
Pulmonary Disease, Chronic Obstructive
/ diagnosis
Retrospective Studies
Severity of Illness Index
Time Factors
Treatment Outcome
COPD
continuity of patient care
exacerbation
patient care bundles
patient readmission
Journal
International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481
Informations de publication
Date de publication:
Historique:
entrez:
19
2
2019
pubmed:
19
2
2019
medline:
30
7
2019
Statut:
epublish
Résumé
Acute exacerbations of COPD (AECOPD) are frequent and associated with a poor prognosis. A home discharge care bundle, the PRADO-BPCO program, has been set up by the French National Health System in order to reduce readmission rate after hospitalization for AECOPD. This program includes early consultations by the general practitioner, a nurse, and a physiotherapist after discharge. The aim of our study was to evaluate the effect of the PRADO-BPCO program on the 28-days readmission rate of COPD patients after hospitalization for AECOPD. This was a retrospective cohort study including all patients admitted for AECOPD in our center between November 2015 and January 2017. The readmission or death rate at 28 days after hospitalization for AECOPD was compared between patients included in the PRADO-BPCO program and patients with standard care after discharge. Inclusion in the program was decided by the physician in charge of the patient. A total of 62 patients were included in the PRADO-BPCO group and 202 in the control group. At baseline, patients in the PRADO group had a more severe COPD disease and more severe exacerbations than the control group and mean inpatient stay was shorter in the PRADO group: 8.6±4.3 vs 10.4±7.4 days ( In our center, despite more severe COPD and a shorter hospitalization time, the PRADO-BPCO program failed to prove a benefit on the 28 days readmission or death rate when compared with standard care.
Identifiants
pubmed: 30774326
doi: 10.2147/COPD.S178147
pii: copd-14-289
pmc: PMC6349078
doi:
Types de publication
Journal Article
Langues
eng
Pagination
289-296Déclaration de conflit d'intérêts
Disclosure The authors report no conflicts of interest in this work.
Références
Thorax. 2003 Feb;58(2):100-5
pubmed: 12554887
Thorax. 2005 Nov;60(11):925-31
pubmed: 16055622
Chest. 2007 Jan;131(1):20-8
pubmed: 17218552
Int J Chron Obstruct Pulmon Dis. 2007;2(3):241-51
pubmed: 18229562
N Engl J Med. 2010 Sep 16;363(12):1128-38
pubmed: 20843247
Arch Intern Med. 2010 Oct 11;170(18):1664-70
pubmed: 20937926
Thorax. 2011 Jul;66(7):602-8
pubmed: 21597112
Thorax. 2012 Feb;67(2):117-21
pubmed: 21896712
Thorax. 2012 Nov;67(11):957-63
pubmed: 22684094
Eur Respir J. 2012 Aug;40(2):495-6
pubmed: 22855468
Int J Chron Obstruct Pulmon Dis. 2012;7:653-61
pubmed: 23055714
JAMA Intern Med. 2013 Apr 22;173(8):695-8
pubmed: 23529659
Eur Respir Rev. 2013 Dec;22(130):454-75
pubmed: 24293462
Int J Chron Obstruct Pulmon Dis. 2013;8:641-52
pubmed: 24376348
Am J Respir Crit Care Med. 2014 Mar 15;189(6):634-9
pubmed: 24460431
Ann Am Thorac Soc. 2014 Jun;11(5):685-94
pubmed: 24784958
Int J Chron Obstruct Pulmon Dis. 2014 Aug 27;9:871-88
pubmed: 25210449
Chest. 2015 Apr;147(4):999-1007
pubmed: 25356881
Eur Respir J. 2015 Sep;46(3):640-50
pubmed: 26160874
Thorax. 2015 Dec;70(12):1123-30
pubmed: 26194996
PLoS One. 2016 Jun 30;11(6):e0158727
pubmed: 27362765
Rev Mal Respir. 2017 Jan;34(1):1-18
pubmed: 27368501
Thorax. 2017 Jan;72(1):31-39
pubmed: 27613539
Respir Res. 2016 Nov 14;17(1):149
pubmed: 27842545
Int J Chron Obstruct Pulmon Dis. 2017 Jan 31;12:467-475
pubmed: 28203070
Thorax. 2017 Aug;72(8):686-693
pubmed: 28235886
Int J Chron Obstruct Pulmon Dis. 2017 Mar 24;12:989-995
pubmed: 28392683
Int J Chron Obstruct Pulmon Dis. 2017 Mar 27;12:1009-1018
pubmed: 28392685